BioSpace News Archive

Lumenis introduces FoLix™, the first FDA-cleared proprietary fractional laser for hair loss treatment

Lumenis Be. Ltd., a leading energy-based medical device company for aesthetic and eye care solutions, is proud to announce the launch of its breakthrough laser system designed to combat hair loss.

June 5, 2024
·
3 min read
Pharm Country

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Insmed Incorporated today announced that management will present in a fireside chat at the Goldman Sachs 45 th Annual Global Healthcare Conference in Miami on Monday, June 10, 2024, at 10:00 a.m.

June 5, 2024
·
1 min read
BioCapital

REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)

REPROCELL USA is proud to announce that it has received funding from MSCRF for both proposals it has submitted for the MSCRF’s January 2024 grant cycle.

June 5, 2024
·
2 min read
Drug Development

HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1

Harmony Biosciences (Nasdaq: HRMY) presented data from its Phase 2 signal detection study showing that pitolisant reduced excessive daytime sleepiness (EDS) and fatigue in adults with Myotonic dystrophy Type 1 (DM1).

June 5, 2024
·
12 min read
Biotech Bay

Nutcracker Therapeutics Demonstrates Enhanced Activity of B Cell Lymphoma Candidate NTX-472 at the 2024 ASCO Annual Meeting

Nutcracker Therapeutics, Inc. recently presented a poster on NTX-472, its new preclinical drug candidate for B cell lymphoma, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

June 5, 2024
·
3 min read
Business

Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year

Celerion, a leading clinical research organization, is pleased to announce it has received a CRO Leadership Award for the ninth time by global biopharmaceutical executives in Life Science Leader’s annual CRO Leadership Awards for 2024.

June 5, 2024
·
2 min read
Pharm Country

Myrtelle Announces that the FDA has selected rAAV-Olig001-ASPA Gene Therapy Candidate for the treatment of Canavan Disease for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program

Myrtelle Inc. today announced that the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) has selected the Company’s gene therapy, rAAV-Olig001-ASPA for the treatment of Canavan disease.

June 5, 2024
·
6 min read
BioMidwest

Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment

Nucleus RadioPharma today announced the closing of a Series A extension round with new investor AstraZeneca (LSE/STO/Nasdaq: AZN).

June 5, 2024
·
4 min read
Biotech Beach

Arcutis Announces Multiple Abstracts, Including Oral Presentation, Accepted at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference

Arcutis Biotherapeutics, Inc. today announced that five abstracts will be presented at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, which will take place in Chicago, IL from June 8-10, 2024.

June 5, 2024
·
5 min read
Business

GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, and Stayhealthy, Inc., a leader in health and wellness technology, are excited to announce a major distribution agreement.

June 5, 2024
·
4 min read